Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shenfu Injection for septic shock
ChiCTR2200065122Phase 4Not yet recruiting
- Sponsor
- Beijing University of Chinese Medicine East Hospital
- Start
- Nov 2021
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of shenfu injection in septic shock (2 arms), sponsored by Beijing University of Chinese Medicine East Hospital. Primary endpoint: 28-day mortality. Planned start Nov 2021; status: not yet recruiting.
02
Drugs
shenfu injection
03
Conditions
septic shock
Beyond the preview
Go deeper on ChiCTR2200065122.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200065122.